CICC Capital, the private equity arm of Hong Kong-listed investment bank China International Capital Corporation Limited (CICC), has raised over 1.6 billion yuan ($229 million) for a biomedicine fund, it said in a statement.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
